Understanding the Ozempic Shot for Weight Loss: Costs and Insights

Last reviewed: July 7, 2026

Last updated: July 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active ingredient in Ozempic, reduces appetite by mimicking glucagon-like peptide-1 (GLP-1), a hormone that signals fullness to your brain. While Ozempic remains in high demand for diabetes management, many people seeking weight loss face supply delays and insurance barriers. PlexusDx offers a direct path to GLP-1 therapy through licensed 503A compounding pharmacies across all 50 states.

How Ozempic Injections Work for Weight Loss

Ozempic contains semaglutide, which belongs to a class of medications called GLP-1 receptor agonists. These drugs slow stomach emptying, reduce hunger signals in the hypothalamus, and help regulate blood sugar levels. Clinical trials show that people using semaglutide lose an average of 10-15% of their body weight over 68 weeks, depending on starting weight and lifestyle changes.

The injectable form delivers medication directly into subcutaneous tissue, allowing steady absorption over a week between doses. Most patients begin with a 0.25 mg injection and gradually increase to therapeutic doses of 1.0 mg or higher, based on tolerance and response. PlexusDx's Compounded Semaglutide Injection follows this same science but comes from licensed 503A compounding pharmacies, providing flexibility without prescription delays.

Ozempic Cost Versus Compounded GLP-1 Alternatives

Brand-name Ozempic typically costs $800 to $1,500 per month without insurance, and many insurers require prior authorization or deny coverage for weight loss use. Patients with insurance often pay $25 to $250 per injection in copays, but supply shortages have made fills unpredictable. PlexusDx's Compounded Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan) regardless of dose level—your dose may need to go up, your price won't.

PlexusDx also offers the Microdose GLP-1 Protocol at $129 per month, designed for patients beginning their GLP-1 journey or preferring lower-intensity therapy. For those seeking dual-action compounds, the GLP-Squared Injection combines semaglutide and tirzepatide at $289/mo month-to-month, or from $249/mo on the 6-month plan. All options are HSA and FSA eligible, require no insurance, and are shipped to all 50 states.

Why Compounded Semaglutide From Licensed Pharmacies Matters

Compounded medications from 503A pharmacies are prepared in state-licensed facilities under USP <797> standards, which govern sterile preparation and quality control. Unlike 503B outsourcing facilities, 503A compounders operate under stricter state pharmacy board oversight and must have direct pharmacist involvement in every batch. PlexusDx partners exclusively with licensed 503A compounding pharmacies to ensure your medication meets pharmaceutical-grade standards.

Compounded semaglutide offers several advantages: no insurance gatekeeping, transparent pricing without dose-level surprises, and faster access when brand-name supplies are constrained. Patients can adjust their dose schedule with their PlexusDx provider without navigating insurance appeals. The medication delivers the same semaglutide molecule as Ozempic, but the pathway to your hands is shorter and more affordable.

Personalized GLP-1 Therapy: The Precision Peptide Genetic Test Advantage

Not every patient responds equally to semaglutide alone. Genetic variations in the GLP-1 receptor gene the glucose-dependent insulinotropic polypeptide receptor (GIPR rs1800437), and appetite-related genes like FTO and MC4R influence how well you'll respond to GLP-1 therapy. PlexusDx's Precision Peptide Genetic Test maps 14 metabolic pathways and 150+ genetic insights for $298.

The test identifies your peptide-pathway predispositions, helping PlexusDx providers optimize your medication choice and dosing strategy. Patients with specific GLP1R variants may benefit from tirzepatide (which activates both GLP-1 and GIP receptors) rather than semaglutide alone. This personalization means you're more likely to reach your weight loss goals faster and experience fewer side effects through evidence-based precision medicine.

Side Effects and Safety Considerations

Common side effects of semaglutide include nausea, vomiting, constipation, and diarrhea, typically mild and decreasing after the first few weeks. Serious but rare side effects include pancreatitis, gallbladder issues, and changes in thyroid nodules (requiring caution in patients with thyroid cancer history). PlexusDx providers screen for contraindications and monitor you throughout treatment to catch and manage any concerns early.

Gradual dose increases—starting at 0.25 mg and moving up by 0.25 mg each week—significantly reduce nausea and other GI side effects. The Microdose GLP-1 Protocol at $129 monthly is ideal for dose-sensitive patients or those with slower tolerance buildup. All PlexusDx patients receive ongoing telehealth support and can communicate with their provider if side effects occur, ensuring adjustments happen quickly without waiting for insurance approvals.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Microdose GLP-1 Protocol is $129/mo flat. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is compounded semaglutide as safe as brand-name Ozempic?

Yes, when sourced from licensed 503A compounding pharmacies. PlexusDx partners only with state-regulated facilities that follow USP <797> sterile preparation standards. The semaglutide molecule is identical; the difference is in manufacturing oversight and cost, not safety.

How much weight can I expect to lose with semaglutide injections?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

What is the total cost of GLP-1 therapy with PlexusDx per year?

PlexusDx's Microdose GLP-1 Protocol costs $129 monthly ($1,548 yearly), while Compounded Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan) ($2,268/year ($189/mo)ly). The optional Precision Peptide Genetic Test is $298 as a one-time add-on. All prices are flat regardless of dose level, and HSA/FSA funds cover these costs.

Who should not use semaglutide or GLP-1 medications?

Semaglutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, or severe pancreatitis. Pregnancy and breastfeeding are also contraindications. PlexusDx providers review your full medical history before prescribing to ensure safety.

How does the Precision Peptide Genetic Test help me choose between semaglutide and tirzepatide?

The test identifies your genetic variants in GIPR and FTO, and MC4R genes, which influence appetite and medication response. Patients with low GLP1R activity may respond better to GLP-Squared (dual compound) or tirzepatide, which activates both GLP-1 and GIP pathways. This genetic insight allows PlexusDx to match you with your most effective option from day one.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic
• Ozempic Weight Loss Before And After Pictures

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.